Α5IA
id:
5ia-164-4496261
title:
Α5IA
text:
α5IA (LS-193,268) is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABAA receptor. It binds to α1, α2, α3 and α5 -containing subtypes, with functional selectivity for α5-containing subtypes.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/%CE%915IA
date created:
2008-09-04T00:19:06Z
date modified:
2024-08-28T21:12:55Z
main entity:
{"identifier":"Q8083967","url":"https://www.wikidata.org/entity/Q8083967"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/6d/Alpha5IA.svg","width":512,"height":543}
fields total:
13
integrity:
16